Skip to main content
. Author manuscript; available in PMC: 2015 May 13.
Published in final edited form as: Lancet Diabetes Endocrinol. 2013 Aug 20;1(3):183–190. doi: 10.1016/S2213-8587(13)70048-2

Table 9.

Dementia risk by each level of the risk score in the validation cohort.

Sum
score
Number at riska Dementia casesb Mean time to
incident dementia
Observed ten year
dementia riskc
N (%) N (%) Mean in y ±SD (95% CI)
−1 230(9·5%) 4 (1·7%) 9·5 ±0·0 3% (1 -7)
0 85 (3·5%) 4 (4.7%) 7·4 ±0·1 7% (3 -18)
1 90 (3·7%) 3 (3·3%) 7·2 ±0·1 4% (1-12)
2 268 (11·1%) 8 (3·0%) 9·4 ±0·1 4% (2-8)
3 125 (5·2%) 9 (7.2%) 7·8 ±0·1 9% (5-16)
4 294 (12·2%) 25 (8.5%) 9·1 ±0·1 11% (8-16)
5 215 (8·9%) 28 (13.0%) 8·8 ±0·1 17% (12-24)
6 289 (12·0%) 50 (17.3%) 8·9 ±0·2 26% (20-33)
7 317 (13·1%) 53 (16.7%) 8·7 ±0·2 22% (17-29)
8 181 (7·5%) 42 (23.2%) 8·2 ±0·2 36% (28-46)
9 139 (5·8%) 43 (30.9%) 7·3 ±0·3 50% (29-62)
10 100 (4·1%) 34 (34.0%) 6·4 ±0·4 64% (47-82)
11 27 (1·1%) 11 (40.7%) 6·1±0·7 61% (37-86)
12-19 21 (0·69%) 9 (42·9%) 3·5 ±0·5 58% (32-86)
a

Number at risk: number of subjects within each sum score group, with percentage of the total cohort in brackets.

b

Number of dementia cases in this sum score group: the percentage is the proportion of persons with incident dementia in that particular sum score group.

c

based on Kaplan-Meier estimates.